Image Credit: Health and me
There's been an alarming increase of respiratory and gastrointestinal viruses in the United States lately, causing anxiety about a so-called "quad-demic". According to surveillance reports, influenza, COVID-19, RSV and norovirus are at very high levels everywhere. While the surge aligns with patterns typical for this season, several epidemiologists view simultaneous infections of such proportions to pose risks not only to individual healthcare but public health.
The incidence of the quad-demic should vary with seasonal patterns, vaccination rates, and public health interventions. Each virus alone is relatively easy to manage; however, the effect of all together could lead to overburdening of health care facilities and increase risks for those at higher risk. Continuing surveillance, early testing, and proactive prevention measures will play an important role in the control of these infections going forward.
While the term "quad-demic" sounds daunting, it must be taken into perspective. For years, we have had all these viruses together, and we have the capabilities to mitigate some of the risk. Vaccination, proper hygiene and using common sense helps individuals get through the season unscathed. Is the quad-demic a permanent fixture or just another seasonal wave? Let's break this down.
Typically, flu, COVID-19, and RSV have been the primary culprits behind seasonal respiratory infections. However, norovirus, a highly contagious stomach bug, has emerged as a fourth significant player, inducing fears of a more severe and widespread viral outbreak. According to the Centers for Disease Control and Prevention (CDC), the U.S. recorded nearly 500 norovirus outbreaks between August and December 2023, a substantial rise from the previous year’s numbers.
While the term "quad-demic" may sound ominous, the seriousness and consequences of such infections should be weighed in light of the U.S. healthcare system's experience with managing viral surges since the start of the COVID-19 pandemic.
Flu continues to be one of the most common and alarming seasonal illnesses. In the period spanning from 2023 to 2024, there were approximately 40 million cases of flu, and thousands of hospitalizations along with reported 47 deaths have been reported this season. Flu symptoms include fever, chills, cough, sore throat, muscle pain, and fatigue, with most recovering within a week or two but risky factors for severe illness effects occur in young children, elderly, and people with chronic conditions.
Despite its reduction from the first pandemic peak, COVID-19 is still rampant. The CDC estimates that alone between October and December 2023, there were between 2.7 and 5 million cases in the U.S. Hospitalization has increased by cities such as Los Angeles, Chicago, and New York. Symptoms are closely similar to the flu, fever, cough, and fatigue but uniquely presents in some cases as loss of taste and smell.
RSV is the most common cause of lower respiratory infections in infants, older adults, and immunocompromised individuals. While RSV peaked late in 2023 and early 2024, it continues to be a threat because it can lead to bronchiolitis and pneumonia. It is very similar to the common cold, presenting with symptoms such as congestion, runny nose, coughing, and fever, which can make it difficult to differentiate from flu or COVID-19 without testing.
Norovirus, also called the "stomach flu," is a highly contagious infection of the gastrointestinal tract, not a respiratory virus. It transmits quickly from contaminated food and water and contact with contaminated surfaces, causing such symptoms as diarrhea, vomiting, nausea, and stomach pain. Cases have shot up, the CDC said Monday, with reports of outbreaks surging compared with last year.
The greatest challenge during the quad-demic is how the four viruses are alike and thus make identification very hard with no testing applied. Most cases present symptoms common to all viruses: fever, tiredness, body pains, and respiratory, which includes coughing and congestions for influenza, COVID-19, and RSV; the other would be norovirus symptoms as nausea and vomiting can appear even in extreme influenza and COVID-19. This overlap increases the risk of misdiagnosis and delayed treatment, hence the need for early testing and proper medical guidance.
Also Read: Is US Preparing For A Quad- demic 2025?
The best defense against these viruses is a combination of vaccines, hygiene, and lifestyle precautions. While lifestyle modifications are highlighted as part of the constant need to eat healthy, ensure daily movement and drinking adequate amount of fluids. There is a sure short two preventive strategies that are effective:
While debates on masked wear continue on, experts on mask-wear affirm that this does not only have a historical precedent but works towards reducing airborne viruses spreading within the environments. Hospitals, though, ensure masking in key sections of themselves. Publicized mask-wear remains a discretion, though massing indoors still goes a longer way in cases like peak flu seasons.
If you notice the symptoms of these viruses, then it's best to be confined at home and avoid having face-to-face interaction with others and seek immediate attention from your physician if your condition worsens. Quarantining for some days can decrease the spread of infection.
As we move into the first half of 2025 and beyond, staying informed and proactive is the best strategy for maintaining health and avoiding unnecessary panic. The key takeaway? Stay vigilant, but don’t be alarmed—these viruses are here, but so are the means to fight them.
Credits: AI GENERATED
In a serious caution to the public, Dr Uma Kumar, Head of Rheumatology at AIIMS New Delhi, has warned against using AI chatbots such as ChatGPT for medical self-diagnosis. As reported by Hindustan Times, she issued the warning while speaking to the media after a recent case at the institute exposed the risks of acting on automated health advice.
The concern followed an incident in which a patient developed severe internal bleeding after treating back pain based on suggestions generated by an AI chatbot. The patient consumed non-steroidal anti-inflammatory drugs without consulting a doctor or undergoing basic medical tests.
According to doctors at AIIMS, the patient relied on an AI tool to manage persistent back pain instead of seeking clinical care. The chatbot recommended commonly used painkillers, which the patient purchased and took independently.
As Hindustan Times noted, the AI system had no access to the patient’s medical history or their risk of stomach and intestinal complications. What appeared to be a routine solution resulted in a life-threatening episode of internal bleeding.
Doctors say this reflects a growing pattern, where quick online answers are replacing medical evaluation, even for drugs that are widely available over the counter.
Dr Kumar explained that medical diagnosis follows a structured process known as diagnosis by exclusion. Doctors rule out possible causes through examinations, laboratory tests, imaging, and patient history before deciding on treatment.
An AI model, however, works by identifying patterns in data. It cannot examine a patient, detect physical warning signs, or judge whether a symptom points to a deeper problem. In this case, proper investigations would likely have revealed a high risk of bleeding, a step that was entirely bypassed.
Medical experts are increasingly concerned about what are often called AI hallucinations, where chatbots present information with confidence despite gaps or inaccuracies.
While platforms such as ChatGPT include disclaimers, their tone can appear authoritative, particularly to someone in pain. As highlighted by Hindustan Times, the recommendation to use NSAIDs was not unusual in general practice, but for this patient, it proved dangerous.
Without a doctor to check for contraindications or underlying conditions, even a common suggestion can lead to serious harm.
The incident has renewed debate over how AI platforms should handle health-related queries. AIIMS doctors are urging the public to treat online tools as sources of general information rather than personal treatment guides.
Experts believe AI can assist healthcare in limited roles, such as research support or administrative tasks, but should never replace professional diagnosis or supervision.
There are also calls for stronger public awareness and clearer regulation to prevent similar incidents. Doctors continue to stress that medical judgment, built on examination and evidence, cannot be replaced by algorithms.
Credits: AI GENERATED
The Delhi High Court has turned down a Japanese company’s attempt to secure a patent for a cancer detection technique that relies on nematodes, or roundworms, ruling that it falls under diagnostic processes that cannot be patented under Indian law, regardless of how novel or non-invasive it may be.
Hirotsu Bio Science approached the High Court after India’s Controller of Designs and Patents rejected its patent application in August 2023, stating that the invention did not meet the criteria laid out in the Patents Act, 1970. In a detailed 25-page judgment delivered on Saturday, Justice Tejas Karia reaffirmed Section 3(i) of the Act, which clearly bars the patenting of diagnostic methods.
The nematode-based cancer detection method is a research-stage technique that uses microscopic roundworms, known as nematodes, to detect the presence of cancer. These organisms possess a highly developed sense of smell, allowing them to pick up on specific chemical cues released by cancer cells in bodily samples such as urine, breath, or tissue, as per Science Direct.
Laboratory experiments have shown that certain nematodes tend to move towards samples taken from individuals with cancer while avoiding those from healthy people. The underlying idea is that cancer changes the body’s chemical profile, creating odour patterns that these worms can detect, sometimes even at an early stage.
Scientists have looked at this approach as a potentially affordable and non-invasive screening option. However, it remains a concept under study and has not yet been accepted as a reliable medical test or used in routine clinical care.
At the centre of the case was a patent application titled “Cancer detection method using the sense of smell of nematode.” Nematodes, often referred to as roundworms, are among the most widespread life forms on the planet and can be found in environments ranging from soil to living organisms.
The Japanese company aimed to patent a technology based on the biological response of Caenorhabditis elegans, a species of nematode recognised for its advanced olfactory abilities.
The firm explained that its invention relies on the chemotaxis of these worms, meaning their tendency to move towards or away from certain scents, which would serve as a biological signal for the presence of cancer.
According to the company, the nematodes showed avoidance behaviour when exposed to urine from healthy individuals, while being drawn towards urine samples from cancer patients. It claimed the method demonstrated complete accuracy during testing and could detect several cancers, including gastric, colorectal, and pancreatic cancers, even at very early stages.
The main legal question was whether the method qualified as a non-patentable “diagnostic process” under Section 3(i) of the Patents Act, 1970. This provision excludes from patent protection any process related to medicinal, surgical, curative, preventive, diagnostic, or therapeutic treatment of humans.
Hirotsu Bio Science Inc challenged the rejection by the Controller of Designs and Patents in the High Court, arguing that their invention should be seen as a “detection” method rather than a “diagnostic” one. The company maintained that the process was carried out entirely in a laboratory setting, using samples such as urine or tissue, and did not involve any direct medical procedure or clinical decision-making on the human body.
Credit: Canva
Health officials have issued a recall for the Live It Up Super Greens supplement powder after 45 people across 21 states were found suffering from salmonella across the US.
The Food and Drug Administration and Centers for Disease Control and Prevention issued an official recall on January 14 for the Live it Up Original and Wild Berry Super Greens dietary supplement powder flavors.
The affected products with expiration dates from August 2026 and January 2028 have been affected by this recall and include:
Authorities has advised consumers to not eat, sell or serve the affected Live it Up-brand products and to contact the company for returns.
Additionally, officials are asking people to wash items and surfaces that may have touched the recalled super greens supplement powders using hot soapy water or a dishwasher.
Of the 45 illnesses, 12 resulted in hospitalizations, according to the FDA. No deaths linked to the recall have been reported.
Apart from this, other symptoms include:
Most people develop symptoms within 8 to 72 hours after exposure while most healthy people recover within a few days to a week without specific treatment. However, in some cases, diarrhea can cause severe dehydration and requires prompt medical attention.
While anyone can contract salmonella, children younger than five, elderly and people with weakened immune systems are more likely to develop severe infections.
Life-threatening complications may develop if the infection spreads beyond the intestines to other organs. The risk of getting salmonella infection is higher with travel to countries without clean drinking water and proper sewage disposal.
While most people do not require medical attention for salmonella infection, those at high risk may need a health care provider if the infection lasts more than a few days, is associated with high fever or bloody stools and appears to be causing dehydration, with signs such as such as urinating less than usual, dark-colored urine as well as having a dry mouth and tongue.
© 2024 Bennett, Coleman & Company Limited